DOI: http://dx.doi.org/10.18203/issn.2455-4529.IntJResDermatol20200607

Clinical trends of scalp alopecia areata: a tertiary care hospital based observational study

Pallavi Singh, Milind A. Patvekar, Bhavika Shah, Alisha Mittal, Asmita Kapoor

Abstract


Background: Alopecia areata is one of the commonest types of non-scarring alopecia involving the scalp and/or body. As there is paucity of recent epidemiological data from our country, this study was conducted to determine the latest clinical and epidemiological trends of scalp alopecia areata.

Methods: A hospital-based observational study consisting of 100 cases of clinically diagnosed scalp alopecia areata who reported to the Dermatology OPD, Dr. D.Y. Patil Medical College, Pune, was conducted for a period of six months. Socio-demographic and clinical information was collected and clinical examination was performed on all patients. The data was evaluated using appropriate statistical methods.

Results: Out of the 100 cases enrolled, males (64%) outnumbered females (36%). The commonest presenting age group was 21-30 years (44%). Disease onset was sudden in 80% patients and 59% cases had a progressive disease course. Majority (75%) had a disease duration of less than 3 months. Majority cases were asymptomatic (80%) with no precipitating factors (90%). Past history and family history of alopecia areata were present in 13% and 9% cases, respectively. Personal and family history of associated diseases were present in 27% and 22% patients, respectively. Most patients had single (61%), patchy (83%) lesions with occiput (45%) being the commonest initial site. Nail changes were present in 22% cases, of which pitting (13%) was the commonest nail finding.

Conclusions: This study reflects the clinical profile of scalp alopecia areata in a tertiary care hospital.


Keywords


Alopecia areata, Alopecia areata pattern, Alopecia areata nail changes, Scalp

Full Text:

PDF

References


Seetharam KA. Alopecia areata: An update. Indian J Dermatol Venereol Leprol. 2013;79:563-75.

Sharma VK, Dawn G, Kumar B. Profile of alopecia areata in Northern India. Int J Dermatol. 1996;35:22-7.

Kaur S, Mahajan BB, Mahajan R. Comparative Evaluation of Intralesional Triamcinolone Acetonide Injection, Narrow Band Ultraviolet B, and their Combination in Alopecia Areata. Int J Trichol. 2015;7(4):148-55.

Tan E, Tay YK, Goh CL, Chin Giam Y. The pattern of alopecia areata in Singapore- A study of 219 Asians. Int J Dermatol. 2002;41:748-53.

Fricke ACV, Miteva M. Epidemiology and burden of alopecia areata: a systematic review. Clin Cosmet Investig Dermatol. 2015;8:397-403.

Fahim S, Montazer F, Tohidinik HR, Naraghi ZS, Abedini R, Nasimi M, et al. Serum and tissue angiotensin-converting enzyme in patients with alopecia areata. Indian J Dermatol Venereol Leprol. 2019;85:295-9.

Strazzulla LC, Wang EHC, Avila L, Sicco KL, Brinstor N, Christiano AM, et al. Alopecia areata: Disease characteristics, clinical evaluation and new perspectives on pathogenesis. J Am Acad Dermatol. 2018;78:1-12.

Wasserman D, Guzman-Sanchez DA, Scott K, McMichael A. Alopecia areata. Int J Dermatol. 2007;46:121-31.

Finner AM. Alopecia Areata: clinical presentation, diagnosis and unusual cases. Dermat Ther. 2011;24:348-54.

Huang KP, Mullangi S, Guo Y, Qureshi AA. Autoimmune, atopic, and mental health comorbid conditions associated with alopecia areata in the United States. JAMA Dermatol. 2013;149:789-94.

Muller SA, Winkelmann RK. Alopecia areata- an evaluation of 736 patients. Arch Dermatol.1963;88:290-7.

Alkhalifah A. Alopecia Areata Update. Dermatol Clin. 2013;31(1):93-108.

Kranseler JS, Sidbury R. Alopecia areata: Update on management. Indian J Paediatr Dermatol. 2017;18:261-6.

Hordinsky M, Ericson M. Autoimmunity: Alopecia areata. J Investig Dermatol Symp Proc. 2004;9:73-8.

Pratt CH, Lloyd E, Messenger AG, Christiano AM, Sundberg JP. Alopecia Areata. Nat Rev Dis Primers. 2017;3:17011.

Hordinsky MK. Overview of alopecia areata. J Investig Dermatol Symp Proc. 2013;16(1):S13-5.

Wang SJ, Shohat T, Vadheim C, Shellow W, Edwards J, Rotter JI. Increased risk for type 1 (insulin-dependent) diabetes in relatives of patients with alopecia areata. Am J Med Genet. 1994;51:234-9.

Guzmán-Sánchez DA, Villanueva-Quintero GD, Alfaro Alfaro N, McMichael A. A clinical study of alopecia areata in Mexico. Int J Dermatol. 2007;46(12):1308-10.

Gandhi V, Baruah MC, Bhattacharaya SN. Nail changes in alopecia areata: incidence and pattern. Ind J Dermatol Venereol Leprol. 2003;69(2):114-5.

Kasumagic-Halilovic E, Prohic A. Nail changes in alopecia areata: frequency and clinical presentation. J Eur Acad Dermatol Venereol. 2009;23(2):240-1.

Darwin E, Hirt PA, Fertig R, Doliner B, Delcanto G, Jimenez JJ. Alopecia Areata: Review of Epidemiology, Clinical Features, Pathogenesis, and New Treatment Options. Int J Trichol. 2018;10(2):51-60.

Madani S, Shapiro J. Alopecia Areata Update. J Am Acad Dermatol. 2000;42:4:549-66.